Be careful people. This new combo looks better than Ivo in 1st line NSCLC: https://www.fiercepharma.com/pharma/merck-kelun-sac-tmt-adc-combo-beats-keytruda-65-progression-first-line-lung-cancer
LazyEyeStonk
praėjusį mėnesį
Hmmm, good entry ?
Squeezed hard, but support is around 16. You guys piling on still ?
Lolopolo
prieš 2 mėnesius
WOW
Holly short squeeze.
Lolopolo
prieš 2 mėnesius
Nobody here fr???
Ain't no way this community is dead. What's y'all gain?
Lolopolo
prieš 4 mėnesius
Fourth quarter and full-year 2025 financial results today
Y'all think Duggan gonna pull out smth unexpected data or collaboration on this conference call?
Lolopolo
prieš 5 mėnesius
anyone?
Helloooooooooooooooooo
NoRiskNoFun
prieš 8 mėnesius
Summit Therapeutics Q3 2025 earnings 📊
Warrior8
prieš 11 mėnesių
Nice run today
Waiting for it hitting $32 again
Screwedontesla
prieš 11 mėnesių
Good luck all
This has been a beauty of a stock for me for the last 1.5 years (time flies!). Made close to 5 figures profit buying and selling over this time. I definitely could have made more but not perfect in trading for sure. Not saying this to brag but to show that if you REALLY know a company and can tie that to the stock market, you can make tons more than long term holding. This is a rarity tbh but it's possible for sure.
With the rumours of a AZ "partnership", I think it's time to call it a day. Really not sure if it's true or what a final deal will look like but it will certainly curb max price. There's a tiny chance I jump back in if it drops and no deal is announced in the future. I will still try and get a job at SMMT IF they haven't sold UK/EU rights to someone! Hopefully it leads to mega profits for everyone still in 🍾
Aliraja
praėjusiais metais
Hi
Can it go 30£ ? I some time
Loser100
praėjusiais metais
Common
18 Billions cap ... Push it up
Loser100
praėjusiais metais
Why it's not growing
Everywhere I checked it has positive news but still not growing 😞🫣
Loser100
praėjusiais metais
Someone
Have any news about this stock... Please share
R14NCHOHAN
praėjusiais metais
Guys
Anyone else shorting?
Aliraja
praėjusiais metais
Hi
Anyone here what happened to this stock today.just bought at 23£
BetsKD
praėjusiais metais
Yay
drhaiderz
praėjusiais metais
I bought it here
BetsKD
praėjusiais metais
Painful
Painful Monday drop
BetsKD
prieš 2 metus
Woulda coulda
Every time I see this beautiful stock, I wish I'd stuck a few 1000 on 😅
Šiame puslapyje gali būti bendruomenės sukurto turinio, už kurį „Trading 212“ neatsako. Visada atlik savo tyrimą. „Trading 212“ teikia tik vykdymo paslaugą, bet neteikia investavimo konsultacijų ar portfelio valdymo paslaugų.
Turto kaupimas – įprotis. Automatizuokite jį naudodami Pies.
Investuok į paruoštus arba susikurk savo investicijų rinkinius, pasirinkdamas iš daugybės vertybinių popierių ir ETF
Sužinok daugiau
Sužinok daugiau
Žiūrėti vaizdo įrašą
Turėk net brangiausių akcijų, tokių kaip „Google“, „Amazon“ ir „Apple“
Žiūrėti vaizdo įrašą
„Euronext“ Paryžius
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londono vertybinių popierių birža
„Euronext Lisbon“
„Euronext“ Paryžius
NYSE, NASDAQ
Xetra, Gettex
Euronext Amsterdam
Bolsa de Madrid
Wiener Börse
Londono vertybinių popierių birža
„Euronext Lisbon“
Peržiūrėk visas prekybos priemones
Pagalba visą parą
29 sekundžių vidutinis atsako laikas
Pradėk kaupti turtą jau dabar
Prisijunk prie daugiau nei 5 mln. naudotojų
Atsisiųsti programėlę
Atidaryti sąskaitą
Atsisiųsk mobiliąją programėlę
Visi pateikti statistiniai duomenys yra globalūs. Klientų skaičius atspindi finansuotas sąskaitas.
Puiku
Įvertinta 4,6/5, remiantis 94 215 atsiliepimais apie
Trustpilot
Įvertinta 4,6/5, remiantis 94 215 atsiliepimais apie
Trustpilot
Pakviestas
Best % for £
Very easy to use. Best saving account.
Pakviestas
It’s made investing pretty easy..
It’s made investing pretty easy in fairness. It’s not made me a bunch of cash, but I can’t blame Trading 212 for that 😄
I chose risk, I won some, I lost some and I’m currently about Even Stevens, which's probably isn’t bad for my first few months trading while taking risks. It’s been a learning curve.
You can take it sensibly and likely make small percentage profits, or you can be more of a gambler. I’m a risk taker, but I definitely need to be careful it doesn’t just become gambling.
The app is good in that it warns you when you’re talking risks. And it’s trustworthy. I always feel completely trusting that my money is safe in terms of Trading 212 doing their bit well.
I can’t ask for more than that 😊
Pakviestas
Great to watch your investment grow…
Great to watch your investment grow each day fab app
Pakviestas
The app is so user friendly and the…
The app is so user friendly and the interface is amazing 👏
Pakviestas
Best platform for new traders
Very easy to use. User friendly, best platform for new traders.
Pakviestas
Money transfer from Tading212 is Instantly
I have had no issues with them.
I get regular updates on my interest
I have 24x7 access to my money
Pakviestas
Easy to use
Easy to use. Incredibly understandable even for beginners for trading
Pakviestas
I like seeing daily interest
I like seeing daily interest. Much happiness very dopamine.
Pakviestas
Super easy to set up
Super easy to set up. The app shows your interest clearly. Definitely recommend
Pakviestas
User friendly app…
Really easy to set up and daily notifications so you can see how the interest is growing on your investment.
Pakviestas
great way to save my money
i live the idea of the daily interest it make me want to save more
Pakviestas
Very easy App to use
Very easy App to use. Good interest rate on cash ISA. It was simple signing up, and even easier to move funds into the new account. So far - so good!
Very intuitive software.
Excellent service all round, and my one query was answered quickly & efficiently!
A 4.76% initial interest rate is excellent!!!
Pakviestas
Excellent and informative
Excellent and informative. Gives you an update daily on your interest. Very unlike my Bank did and I get a brilliant interest rate. I was told Trading 212 was excellent and I was not disappointed.
Pakviestas
User friendly such a good platform to…
User friendly such a good platform to invest
Pakviestas
All good
All good. I have not encountered any downsides so far.
Pakviestas
Financial discipline
I am able to cultivate a culture of discipline with trading 212
Pakviestas
Easy of use and clarity of information.
Easy of use and clarity of information.
Pakviestas
Easy to use app with very clear costs
Easy to use app with very clear costs
Pakviestas
Easy to set up a pie
Easy to set up a pie! Im new at this but still managed to do it.
Pakviestas
Amazing and practical app
Amazing and practical app - way better in functionality and customer support than other trading apps in Germany!
Pateikiami keli teigiami mūsų klientų atsiliepimai
Mūsų apdovanojimai
Dažniausiai užduodami klausimai
Kokia yra Summit Therapeutics (SMMT) akcijos kaina?
Dabartinė Summit Therapeutics (SMMT) kaina yra 14,29 $.
Koks yra SMMT52 savaičių maksimumas?
52 savaičių maksimumas SMMT yra 30,91 $.
Koks yra SMMT 52 savaičių žemiausias lygis?
52 savaičių žemiausias SMMT kursas yra 13,81 $.
Koks yra SMMT savaitės rezultatas?
Per pastarąją savaitę SMMT kaina pasikeitė −3,84 %.
Koks yra SMMT mėnesio našumas?
Per pastarąjį mėnesį SMMT kaina pasikeitė −20,96 %.
Koks yra SMMT 3 mėnesių rezultatas?
Per pastaruosius tris mėnesius SMMT kaina pasikeitė −5,43 %.
Koks yra SMMT 6 mėnesių rezultatas?
Per pastaruosius šešis mėnesius SMMT kaina pasikeitė −23,25 %.
Koks yra SMMTmetinis našumas?
Per pastaruosius metus SMMT kaina pasikeitė −30,6 %.